Smith & Nephew PLC (SNN)
24.80
+0.44
(+1.81%)
USD |
NYSE |
Apr 23, 16:00
24.54
-0.26
(-1.05%)
Pre-Market: 09:06
Smith & Nephew EPS Diluted (TTM): 0.602 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.602 |
June 30, 2023 | 0.4992 |
December 31, 2022 | 0.5093 |
June 30, 2022 | 1.129 |
December 31, 2021 | 1.191 |
June 30, 2021 | 1.260 |
December 31, 2020 | 1.022 |
June 30, 2020 | 0.8855 |
December 31, 2019 | 1.362 |
Date | Value |
---|---|
June 30, 2019 | 1.594 |
December 31, 2018 | 1.514 |
June 30, 2018 | 1.638 |
December 31, 2017 | 1.754 |
June 30, 2017 | 1.958 |
December 31, 2016 | 1.756 |
June 30, 2016 | 0.794 |
December 31, 2015 | 0.912 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
0.4992
Minimum
Jun 2023
1.594
Maximum
Jun 2019
1.005
Average
1.075
Median
EPS Diluted (TTM) Benchmarks
AstraZeneca PLC | 1.915 |
Adaptimmune Therapeutics PLC | -0.4738 |
Biodexa Pharmaceuticals Plc | -402.00 |
Verona Pharma PLC | -0.72 |
NuCana PLC | -16.46 |